Nasal Drug Delivery Systems Market
In 2024, the World Health Organization (WHO) reported about 50 million patients worldwide suffering from epilepsy.
According to MarkNtel Advisors study, The Global Nasal Drug Delivery Systems Market size was valued at USD 65.06 billion in 2024 and is projected to reach USD 98.40 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.9% during the forecast period, i.e., 2024-30.
The nasal route for delivering drugs, including biologics like peptides, monoclonal antibodies (mAbs), and stem cells, in recent years has gained significant consideration. This has been because it tends to offer the major benefit of being non-invasive in nature as well as being an efficient, and direct route to the systemic circulation or targeted sites within the body thereby providing faster & enhanced drug response. The company like Aptar have also been actively advocating the idea of nasal delivery of biological drugs, peptides, proteins, etc., and have been exploring technologies like spray drying and spray freeze-drying for the success of nasal drug delivery of biologics. Also, as the importance of biologics has been increasing for treating certain types of cancer and autoimmune diseases, as well as for preventing and treating a wide range of diseases and health conditions like anemia & cystic fibrosis, the focus would increase on making them more efficient. This would eventually drive the adoption of nasal drug delivery systems for the successful and faster administration of biological drugs.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Download Free Sample Copy @ https://www.marknteladvisors.com/query/request-sample/nasal-drug-delivery-systems-market.html
Key Findings in Nasal Drug Delivery Systems Market:
| Historical Years | 2019-2022 |
| Base Years | 2023 |
| Forecast Years | 2024-2030 |
| Key Report Highlights | · Market Dimensions & Projections· Pricing Evaluation,· Recent Strategic Moves by Companies,· Primary Stakeholders,· Analysis of Import and Export Trends,· Competitive Landscape Assessment,· Emerging Opportunities,· Market Trends and Indicators |
| Reports Delivery Format | Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address. |
Nasal Drug Delivery Systems Market Key Players:
Becton, Dickinson and Company, 3M, Zeteo Biomedical LLC, Nemera, AptarGroup, Inc., MetP Pharma AG, Bespak Limited (Recipharm), Teleflex Incorporated, Doctor Pack India Private Limited, Hovione, and Others
Market Segmentation Overview:
By System Type
-Unit Dose
-Bi Dose
-Multi Dose
By Container Type
-Non-Pressurized Containers
-Pressurized Containers
By Dosage Form
-Nasal Spray
-Nasal Drops
-Nasal Powders
-Nasal Gels
Out of all, the nasal sprays category expects to hold a significant market share of the Global Nasal Drug Delivery Systems Market. Throughout the world, the mortality rates are escalating due to opioid overdose which in turn results from the misuse of prescription opioids or opioid-based pain medication in a way that physicians don’t prescribe. As a result, the focus of healthcare providers has been on giving emergency response or medications as soon as possible via the utilization of nasal spray-based nasal drug delivery systems. Further, a heightened number of pediatric & adult patients have been witnessing the issue of life-threatening allergic reactions. This tends to successfully escalate the adoption of nasal sprays as these offer safe, faster, & effective administration of medications to save the lives of patients. Hence, considering the aforementioned factors, the market for the nasal sprays category has been expanding.
By Therapeutic Application
-Nasal Congestion
-Rhinitis
-Anaphylaxis
-Asthma
-Migraine
-Others (Opioid overdose, Vitamin deficiencies, etc.)
By End-User
-Hospitals
-Specialty Clinics
-Ambulatory Surgical Centres
-Homecare Settings
Read Full Report @ https://www.marknteladvisors.com/research-library/nasal-drug-delivery-systems-market.html
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
The Nasal Drug Delivery Systems Industry Recent Development:
2023: Hovione announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Note: If you require specific information not covered in the current report, we can provide it through customized option
Explore Related Reports: –
About MarkNtel Advisors:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.
Have an Any Query,
Call Us – US Office: +1 628 895 8081
Email – sales@marknteladvisors.com
Address Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
